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Abstract
The use of implanted devices in modern orthopaedic surgery has greatly improved the quality of life for an increasing number of
patients, by facilitating the rapid and effective healing of bone after traumatic fractures, and restoring mobility after joint replacement.
However, the presence of an implanted device results in an increased susceptibility to infection for the patient, owing to the creation
of an immunologically compromised zone adjacent to the implant. Within this zone, the ability of the host to clear contaminating bacte-
ria may be compromised, and this can lead to biofilm formation on the surface of the biomaterial. Currently, there are only limited data
on the mechanisms behind this increased risk of infection and the role of material choice. The impacts of implant material on bacterial
adhesion, immune response and infection susceptibility have been investigated individually in numerous preclinical in vitro and in vivo
studies. These data provide an indication that material choice does have an impact on infection susceptibility; however, the clinical impli-
cations remain to be clearly determined.
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All patients receiving implanted medical devices are at
increased risk of developing an infection at the surgical site.
This increased susceptibility to infection is observed for all
medical devices, ranging from fracture fixation implants and
prosthetic joints to catheters, shunts, stents, and prosthetic
heart valves. The increase in infection risk is linked to a local-
ized immunological deficit at the interface between the implant
and the host. This immune deficiency leads to a reduced ability
to clear microorganisms from the vicinity of the biomaterial,
and any contaminating bacteria are therefore more likely to
cause a device-associated infection. Thus, the medical device
paradoxically becomes both the cause of and substrate for the
developing infection. This minireview describes the role of the
material of which the medical device is composed and how this
impacts on the development of infection.
The most commonly used materials in modern orthopae-
dic surgery include titanium and its alloys, stainless steel,
cobalt–chromium, and various polymers, including ultra-high
molecular weight polyethylene (UHMWPE), polyetheretherk-
etone, silicone, various ceramics, and hydroxyapatite. These
materials obviously differ widely in both chemical and
mechanical characteristics; however, they all have properties
that make them ideal for use in specific biomedical applica-
tions, such as an appropriate modulus of elasticity, wear
resistance, and a propensity for tissue integration. All of the
aforementioned materials are generally considered to be well
tolerated once implanted into the human body; however, a
detailed understanding of how these materials impact on
infection risk is not yet available.
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The Effect of Implant Material in
Preclinical in vivo Studies
In 1973, Andriole was among the first investigators to real-
ize that foreign bodies could potentiate the development of
osteomyelitis [1]. In this study, rabbit medullary canals were
inoculated with Staphylococcus aureus in either the presence
or the absence of a stainless steel pin [1]. In the presence
of the foreign body, osteomyelitis developed in 88% of
cases, whereas none of those without the pin showed evi-
dence of infection. Later studies then showed that the
actual type of biomaterial implanted into bone could further
affect the chances of developing an infection [2]. Cylinders
composed of stainless steel, cobalt–chromium alloy, high
molecular weight polyethylene, pre-polymerized polymethyl-
methacrylate (PMMA) bone cement or PMMA bone cement
at the doughy, preset stage (i.e. polymerized in vivo) were
inserted into canine femoral canals, and significant variability
in the infection rate between the materials was observed.
PMMA (polymerized in vivo) was found to be the most sus-
ceptible to infection; at the time, this was surmised to be
attributable to the heat created during PMMA polymeriza-
tion and the possibility of toxicity, although the precise
mechanism was not identified, and follow-up mechanistic
studies have not been performed. Heat-induced necrosis of
the local tissues could certainly lead to increased cell death,
and it has been shown that a localized zone of tissue necro-
sis can facilitate bacterial survival [3,4]. It has also been
shown that more subtle effects, such as changes in surface
topography, can also play a role; for example, Cordero et al.
[5] investigated the differences between cobalt–chromium–
molybdenum (CoCrMo) and titanium–aluminium–vanadium
alloys with either a smooth polished surface or a micropo-
rous coating. For both materials, the porous surfaces
required significantly fewer bacteria to cause a bone infec-
tion in rabbits, and this could be attributed to the porous
surfaces providing a site for contaminating bacteria to multi-
ply while shielding them from host immune defences. In a
recent study investigating the numbers of bacteria present
on implants explanted from patients with infected hip and
knee arthroplasties [6], it was found that there was no clear
material-based trend in the numbers of adherent bacteria.
This study had a limited number of cases, and could not
determine whether a particular material was more or less
likely to lead to infection. Interestingly, one of the findings
of this investigation was that, once implants are actually
infected, the total amounts of bacteria growing as biofilms
upon the implants are similar, regardless of the materials of
which they are composed.
Bacterial Adhesion
Bacterial contamination of the implant via adhesion is the first
step towards the development of device-associated infection.
Therefore, initial adhesion to an implant surface is an impor-
tant step in the development of an infection. Bacterial adhe-
sion may occur preoperatively or postoperatively, the key
difference being that, in the postoperative scenario, a condi-
tioning film composed of numerous host proteins is present
on the implant; this distinction is also seen in the literature. A
conditioning film is formed rapidly after implantation, as pro-
teins, such as fibrinogen, fibronectin, and vitronectin, are
adsorbed onto the surface of the device. The exact format of
the conditioning film is dependent on implant surface chemis-
try (charge and hydrophobicity), topography, and exposure
time. This then affects all of the postoperative downstream
events, including cellular and immune responses, tissue inte-
gration, and bacterial adhesion [7]. Many bacteria have mecha-
nisms, such as the microbial surface components recognizing
adhesive matrix molecules of S. aureus, for adhering to the
proteins of host protein conditioning films, and these are con-
sidered to be important virulence factors. Therefore, it is of
importance to quantify bacterial adhesion and, if relevant, the
efficacy of any antimicrobial strategies in the presence of phys-
iologically relevant conditioning films to assess the postopera-
tive contamination risk.
In the absence of a host conditioning film, surface roughness
has been consistently shown to alter and sometimes dominate
bacterial adhesion [8–11]. For example, when standard micro-
rough implant metals such as titanium and titanium–alumin-
ium–niobium alloy, or polymers such as UHMWPE, are com-
pared with smoother variants, there is often a significant
decrease in adhesion to the smoother surfaces when the sur-
face features are of a smaller scale than the contaminating bac-
teria [9,12–14]. Once the bacteria have adhered to the surface
of the biomaterial, it has been shown that expression of the ica
locus, which is involved in staphylococcal adhesion and intra-
cellular aggregation and biofilm formation, is not affected by
the precise substrate upon which the biofilm is formed, as was
observed for polymers and metals, including stainless steel of
varying topographies and titanium [15,16].
Host Response to Biomaterials and
Infection
The host response to an implanted material may be summa-
rized under the somewhat broad term ‘biocompatibility’.
There is no precise definition of biocompatibility, and the
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requirements of biocompatibility are contextual; however,
non-toxicity, integration with the host immune response and
the absence of any deleterious side effects are generally con-
sidered to aid biocompatibility [17]. The final result of the
host response to a foreign material consists of a spectrum of
outcomes, ranging from complete integration with the sur-
rounding tissues resulting in minimal inflammation, through
to chronic inflammation and fibrous encapsulation. The same
host response to the material will also influence the ability of
the host to clear the contaminating pathogens from the
surface of the implant via phagocytes, including polymorpho-
nuclear leukocytes and macrophages [18,19]. One of the first
critical steps in the development of the immune response to
a medical device occurs when the implanted material stimu-
lates the complement cascade. Some highly complement-acti-
vating materials such as silicone, used in the production of
catheters, have been shown to have a greater infection risk
than less stimulatory materials also used as catheter materi-
als, such as polyurethane or polyvinylchloride, both in vitro
and in vivo [20,21]. The mechanism behind this may involve
excessive activation of complement and desensitization of
leukocytes to the activated complement signal, impeding
effective complement function [22]. In a seminal study,
Zimmerli et al. [23] showed, using a tissue cage model, that
polymorphonuclear leukocytes that come into contact with
non-phagocytosable materials develop a deficit in bactericidal
respiratory burst activity and reduced ingestion. In an investi-
gation focusing on the neutrophil response to polystyrene
and a cobalt-based alloy, it was found that the superoxide-
producing ability of neutrophils was not directly affected by
beads of these materials, but that neutrophils incubated with
either biomaterial displayed decreased responses to subse-
quent phorbolmyristate acetate challenge, which is potentially
another mechanism for the reduced local susceptibility to
infection [24]. In this study, the particular type of material
was not found to play a role, at least for those materials
tested; however, in other studies, phagocytosis of bacteria
by macrophages has been shown to be dependent on the
specific biomaterial surface with which they come into con-
tact. In vitro, Saldarriaga et al. [19] showed that bacterial
clearance from cross-linked polyethylene glycol-based coat-
ings by macrophages was enhanced by 20–50% in comparison
with fluorinated ethylene propylene, silicone rubber, and
glass. This was attributed to weak adhesion of bacteria and
greater macrophage mobility on the surfaces. Additionally, a
separate study using a rat subcutaneous implant model
showed that hydrophilic and anionic model surfaces had sig-
nificantly fewer adherent macrophages after 14 and 21 days,
and a significantly higher rate of immune cell apoptosis [25].
It remains to be seen whether such surfaces, which can influ-
ence macrophage behaviour, will become clinically available.
However, the potential for such surfaces is obvious.
In addition to the implanted device, the presence of par-
ticulate debris can also affect infection risk. Hosman et al.
[26] showed that biofilm formation and planktonic growth of
bacteria were both inhibited by chromium and cobalt ions in
a dose-dependent manner. The highest concentration of
metal ions (200 000/93 000 lg/L Co2+/Cr3+) reduced biofilm
formation by 15–26%. However, the lower metal concentra-
tions, simulating circulating serum levels, showed no consis-
tent influence on biofilm formation or on planktonic growth.
In a subsequent in vivo study, it was found that Co–Cr parti-
cles showed a similar infection burden as UHMWPE particles
in four of six mice, with two cases showing significantly
increased levels of infection. The increase in these animals
was attributed to a possible reduction in macrophage func-
tion by the Co–Cr particles [27]. This theory is supported
by evidence showing that both soluble and particulate debris
derived from CoCrMo can induce monocyte–macrophage
activation and the secretion of numerous proinflammatory
cytokines [28]. Even low doses of CoCrMo promote macro-
phage survival (in vitro), which could contribute to the
increased numbers of macrophages in the regions of joint
implant failure and the local inflammatory reaction and oste-
olysis [29].
In another study, standard catheter materials and novel
catheter coatings were implanted subcutaneously into mice
[30]. Despite the prediction that the novel polyvinylpyroli-
done (PVP) coatings should reduce bacterial adhesion, the
infection rate was much higher in animals receiving the PVP
implants. It was found that, around the polyamide–PVP
implants, intracellular Staphylococcus epidermidis bacteria per-
sisted within macrophages in greater numbers. From the
analysis of cytokine production around the materials, it was
suggested that implant-mediated interleukin-1b production
may lead to increased numbers of intracellular bacteria and
an increased infection risk. This hypothesis was later tested
with interleukin-1 receptor-deficient mutant mice [31]; these
mice were significantly less likely to develop infection. This is
an important finding, because the persistence of intracellular
pathogens around an implanted biomaterial is a major con-
cern, as these bacteria are not as susceptible to antibiotic
treatment as those associated directly with the implant [32].
Influence of Material in Fracture Fixation
Device-related Infections
In the case of orthopaedic devices, the host response of pri-
mary interest for most applications is osseo-integration. Of
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all the commonly used orthopaedic implant materials, tita-
nium leads to the greatest direct osseo-integration. This can
be attributed to the three-dimensional roughness of the clini-
cally used standard titanium, which facilitates osteoblast
attachment and bone integration [33,34]. In contrast,
electropolished stainless steel, which has an extremely
smooth surface, often leads to fibrous–osseous integration.
Considering the obvious and significant effect on cellular
response that occurs, depending on implant surface chemis-
try and topography, there is also a potential impact on infec-
tion susceptibility. The micro-rough surface of commercially
available titanium implants has been shown to confer greater
resistance to infection than electropolished stainless steel in
the rabbit tibia fixed with dynamic compression plates [35].
No clear reason for this effect was identified, other than the
improved biocompatibility of titanium. In a similar model
using low-contact locking plates, which do not cause contact
necrosis to the same extent as the dynamic compression
plates, neither the material nor the topography of the
implant impacted on infection susceptibility [36].
There are surprisingly few clinical data on the infection
rates associated with orthopaedic implants differing in
implant material. A trend towards reduced infection rates
for titanium percutaneous pins [37] and spinal implants [38]
has been identified in some studies; however, they were lim-
ited in numbers, and less than conclusive. The clinical and
the preclinical results indicate that the role of material
choice in infection risk is interlinked with implant design
[39], and the combination of both factors determines the
true susceptibility to infection of an implant.
Designing Surfaces to Combat Infection
The implanted biomaterial also represents a technological
opportunity for biomaterials science to offer design improve-
ments for limiting these infections. Current antimicrobial-
containing materials may be subcategorized on the basis of
their means of achieving antimicrobial action: (i) those that
bind antimicrobial agents directly to the implant surface and
that act only on local bacteria that contact the surface, e.g.
vancomycin covalently linked to titanium [40]; (ii) those that
release the antimicrobial agent from the implanted bulk bio-
material, creating a local zone of killing around the implant,
e.g. gentamicin-loaded PMMA [41]; and (iii) those that
release antibiotic agents from a film or coating over the
implant, e.g. silver-coated endotracheal tubes [42], gentami-
cin-coated intramedullary nails [43], and rifampin–minocy-
cline-coated central venous catheters [44].
To date, the portfolio of antimicrobial agents released
from implanted biomaterials has most often involved tradi-
tional antibiotics. In addition, other antimicrobial agents have
been incorporated into biomaterials. These include silver
nanoparticles [45], quaternary ammonium compounds [46],
peptides [47], furanones [48], nitric oxide [49], and numer-
ous other novel molecular entities [50–52]. Nanotechnology
also offers some promise with regard to minimizing the bur-
den of implant-associated infections, as reviewed by Monta-
naro [53]. Techniques such as micropatterning of antifouling
surfaces have shown that bacterial-repellent and tissue-
friendly surfaces may be achieved [54]. Similarly, nanoparti-
cles other than silver have also been investigated for antibac-
terial efficacy. In one example, Shi et al. [50] incorporated
nanoparticles composed of quaternary ammonium–chitosan
derivatives; it was found that not only did these particles dis-
play antibacterial activity that supplemented the gentamicin
that is often added to the cement, but that they offered anti-
bacterial protection for a longer duration than antibiotic
alone. These studies clearly indicate the potential for the
development of antimicrobial surfaces by the use of novel
microtechnologies and nanotechnologies.
Summary
In general, it seems that implant material can play a role in
all of the most important factors in relation to susceptibility
to infection, including bacterial adhesion, immune activation,
and phagocytosis of bacteria. However, there are only spo-
radic references in the clinical literature focusing on the
topic and the combined role of these features, and this rep-
resents an area requiring greater investigation. To achieve a
significant impact in preventing infection in high-risk cases,
active antimicrobial biomaterials have been developed that
have been shown to have significant clinical impacts in reduc-
ing the incidence of infection. However, for effective transla-
tion of novel biomaterials from the laboratory to the clinic,
the current commonly used preclinical validation methods
must be improved, to more accurately reflect the clinical sit-
uation, including incorporating the influence of conditioning
films and the host response.
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